Blog
6 August 2019
Using CANTAB to enhance pro-cognitive clinical trials in multiple sclerosis
Accurate outcome measures and suitable patient recruitment will be vital to the success of pro-cognitive treatment trials in multiple sclerosis (MS). In this article, we highlight the sensitivity of various CANTAB tasks to cognitive dysfunction in MS, and discuss the advantages of using these computerised assessments over paper-and-pencil based tests. We also consider how CANTAB tasks can be used to screen prospective participants for specific types and severities of cognitive impairment in order to gauge their suitability for inclusion in pro-cognitive intervention trials.
Read on
18 July 2019
Interim Analysis of Online Screening as a Recruitment Strategy for the Models of Patient Engagement in Alzheimer’s disease (MOPEAD) Initiative
At AAIC 2019 we presented an interim analysis of online screening as a recruitment strategy for the MOPEAD initiative. The initial findings are positive, with high levels of engagement from older adults, as well as sensitivity to impairment.
Read on
18 July 2019
Large-Scale Remote Assessment of Verbal Cognitive Function Using Automatic Speech Recognition
At AAIC 2019, we shared how to administer and score verbal neuropsychological assessments on participants own devices in a way that is acceptable, feasible and reliable.
Read on
18 July 2019
Vocalic Markers of Cognitive Load Derived from Automated Verbal Neuropsychological Assessment and Machine Learning in a Large Scale Remote Sample
The effort participants exert in order to complete a task provides the researcher with a rich understanding of their level of functioning. At AAIC 2019, we shared how to derive this cognitive load from voice recordings.
Read on
5 July 2019
How CANTAB is helping to fast track dementia research – DPUK’s Great Minds
With more than two million participants, Dementias Platform UK is a national effort to make real strides in tackling dementia. Leona Wolters from the initiative shared with us the vital role that CANTAB plays in this large-scale cohort study.
Read on
20 June 2019
CANTAB to enhance cognitive assessment in rare neurological diseases
We caught up with psychologist, Lara Draghi, to discuss the value of using CANTAB to assess cognitive function in patients with rare neurological disorders.
